Second-trimester ultrasound, fetal biometrics and gestational diabetes

Published On: 08 Oct, 2022 1:32 PM | Updated On: 19 May, 2024 12:19 PM

Second-trimester ultrasound, fetal biometrics and gestational diabetes

Gestational diabetes mellitus (GDM) is a frequent metabolic complication of pregnancy. Its incidence is increasing worldwide, with 5–25% of pregnancies diagnosed with GDM depending on screening strategies and diagnostic criteria. GDM may cause obstetric complications and increase the offspring's risk of adult metabolic disease. 

Timely identification of GDM helps regulate maternal glucose levels, which considerably reduces obstetric complications. A recent study by Andersen AS. et al. explains the association between second-trimester ultrasound biometrics and GDM. Their study included 2697 singleton pregnancies attending second-trimester ultrasound scans at 20 + 0 to 20 + 6 weeks gestation and giving birth in the year 2020. They included ultrasound measurements like head circumference (HC), abdominal circumference (AC), femur length (FL), and estimated fetal weight (EFW) by Hadlock's formula. The study, however, excluded women with pregestational diabetes. 

The investigators performed GDM screening on indication using an oral-glucose-tolerance-test (OGTT) including 75 g glucose and considered a 2-hour serum glucose value ≥ 9 mmol/L as diagnostic. 

The investigators diagnosed 6.5 % of the participants with GDM; and found the incidence of GDM in pregnancies with biometrics above the 90th centile as; FL: 10.5 %, HC: 8.8 %, AC: 7.6 %, EFW: 9.3 %. They found that Fetal biometrics above the 90th centile was significantly associated with GDM; ORFL = 2.07; ORHC = 1.89; ORAC = 1.63; OREFW = 1.64; and this association remained significant for HC and FL when adjusted for maternal obesity (Body Mass Index ≥ 27): ORHC(adj)=1.56; ORFL(adj) = 1.57.

Through this study, the investigators concluded that fetal biometrics above the 90th centile at the second-trimester scan increases the risk of GDM. 

In pregnancies, diagnosed with GDM in later stages, fetal growth is already increased at the second-trimester scan. These findings underline the importance of early identification of GDM.

Source: Andersen AS, Rathcke SL, Christensen TT, Sørensen A. The association between second-trimester ultrasound fetal biometrics and gestational diabetes. EJOG. 2022;276:139-143. DOI:https://doi.org/10.1016/j.ejogrb.2022.07.015

user
IJCP Editorial Team

Comprising seasoned professionals and experts from the medical field, the IJCP editorial team is dedicated to delivering timely and accurate content and thriving to provide attention-grabbing information for the readers. What sets them apart are their diverse expertise, spanning academia, research, and clinical practice, and their dedication to upholding the highest standards of quality and integrity. With a wealth of experience and a commitment to excellence, the IJCP editorial team strives to provide valuable perspectives, the latest trends, and in-depth analyses across various medical domains, all in a way that keeps you interested and engaged.

 More FAQs by IJCP Editorial Team
Logo

Medtalks is India's fastest growing Healthcare Learning and Patient Education Platform designed and developed to help doctors and other medical professionals to cater educational and training needs and to discover, discuss and learn the latest and best practices across 100+ medical specialties. Also find India Healthcare Latest Health News & Updates on the India Healthcare at Medtalks